» Articles » PMID: 39496767

Clinical Effectiveness of Guided Breathing Exercises in Reducing Anxiety, Stress, and Depression in COVID-19 Patients

Overview
Journal Sci Rep
Specialty Science
Date 2024 Nov 4
PMID 39496767
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic has led to an increase in the prevalence of anxiety, stress and depression among affected people. This study was conducted with the aim of investigating the clinical effectiveness of guided breathing exercises in reducing anxiety, stress and depression in patients with COVID-19. A quasi-experimental study design was used, involving a sample of COVID-19 patients who underwent guided breathing exercises as a complementary therapy. After simple sampling, eligible subjects were randomly divided into two groups: intervention (30 patients) and control (30 patients) using random block method. The Depression Anxiety Stress Scale-21 (DASS-21) questionnaire was administered before and after the intervention to evaluate changes in anxiety, stress, and depression levels. The results of this study demonstrated that clinically guided breathing exercises had a significant effect on reducing anxiety and stress in COVID-19 patients. The intervention significantly reduced anxiety and stress scores (p < 0.001). However, there was no significant reduction in depression scores among patients who participated in guided breathing exercises (p = 0.946). Guided breathing exercises are an effective complementary technique in reducing the level of anxiety and stress in COVID-19 patients. Moreover, the exercises may provide a worthy non-pharmacological approach to managing psychological distress in COVID-19 patients.

References
1.
Baj J, Karakula-Juchnowicz H, Teresinski G, Buszewicz G, Ciesielka M, Sitarz R . COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020; 9(6). PMC: 7356953. DOI: 10.3390/jcm9061753. View

2.
Laires P, Nunes C . Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions. Acta Med Port. 2020; 33(11):720-725. DOI: 10.20344/amp.14222. View

3.
Turna J, Zhang J, Lamberti N, Patterson B, Simpson W, Francisco A . Anxiety, depression and stress during the COVID-19 pandemic: Results from a cross-sectional survey. J Psychiatr Res. 2021; 137:96-103. PMC: 8548032. DOI: 10.1016/j.jpsychires.2021.02.059. View

4.
Rettie H, Daniels J . Coping and tolerance of uncertainty: Predictors and mediators of mental health during the COVID-19 pandemic. Am Psychol. 2020; 76(3):427-437. DOI: 10.1037/amp0000710. View

5.
Ebrahimzadeh G, Omer A, Naderi M, Sharafi K . Human health risk assessment of potentially toxic and essential elements in medicinal plants consumed in Zabol, Iran, using the Monte Carlo simulation method. Sci Rep. 2024; 14(1):23756. PMC: 11467194. DOI: 10.1038/s41598-024-75159-w. View